Polypoidal Choroidal Vasculopathy

• CLINICAL_TRIALS research · 2026-03-10
  Clinical Trial Update: Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy [Phase 3]

  A Phase 3 clinical trial update reports on evaluating a personalized treat-and-extend regimen of Faricimab for treatment-naive polypoidal ch…

• CLINICAL_TRIALS research · 2026-02-12
  Clinical Trial Update: Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) [Phase 1, Phase 2]

  This document describes an ongoing Phase 1/2 clinical trial evaluating the safety, tolerability, and preliminary efficacy of intravitreal AB…

• CLINICAL_TRIALS research · 2026-02-05
  Clinical Trial Update: Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial [Phase 3]

  Phase 3 trial evaluating a personalized high-dose aflibercept (8 mg) regimen for treatment-naive polypoidal choroidal vasculopathy; currentl…

• CLINICAL_TRIALS research · 2026-01-26
  Clinical Trial Update: A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV) [Phase 4]

  Phase 4 clinical trial evaluating different regimens of aflibercept 8 mg in Chinese patients with polypoidal choroidal vasculopathy, assessi…

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment [NA]

  Clinical trial update comparing intravitreal aflibercept monotherapy to aflibercept with reduced fluence PDT for Polypoidal Choroidal Vascul…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2020-10-23
  Clinical Trial Update: Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV) [Phase 4]

  Phase 4 trial updating intravitreal aflibercept for treatment of symptomatic macular polypoidal choroidal vasculopathy (PCV) completed.

• CLINICAL_TRIALS research · 2017-04-25
  Clinical Trial Update: Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases

  This clinical trial update describes a pharmacogenomic study of the anti-VEGF drug Conbercept for macular neovascular diseases, including ag…

• CLINICAL_TRIALS research · 2016-06-29
  Clinical Trial Update: Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers

  This entry provides an update on a clinical trial examining angiographic features of central serous chorioretinopathy (CSC) and polypoidal c…

• CLINICAL_TRIALS research · 2012-11-01
  Clinical Trial Update: IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD [NA]

  Clinical trial update indicates the IRay device is being explored to treat polypoidal choroidal vasculopathy secondary to age-related macula…

• CLINICAL_TRIALS research · 2012-10-25
  Clinical Trial Update: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy [Phase 1, Phase 2]

  Phase 1/2 clinical trial update on treatments for exudative and vasogenic chorioretinal diseases including AMD variants and other CNV-relate…

• CLINICAL_TRIALS research · 2011-05-30
  Clinical Trial Update: Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy [NA]

  This clinical trial update examines aqueous humor cytokine levels in Polypoidal Choroidal Vasculopathy and how cytokines change after photod…